Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year gross profit growth rate
Latest
183.58%
↓ 27% vs avg
Percentile
P92
Near historical high
Streak
1 qtr
Consecutive declineDecelerating
Average
252.31%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 183.58% |
| Q3 2025 | 1908.73% |
| Q2 2025 | 888.49% |
| Q1 2025 | -101.48% |
| Q4 2024 | 50.29% |
| Q3 2024 | 7249.24% |
| Q2 2024 | 96.00% |
| Q1 2024 | -68.58% |
| Q4 2023 | -0.31% |
| Q3 2023 | -113.63% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |